Local protein synthesis and mRNA metabolism mediated by mRNP granules in the dendrites and the postsynaptic compartments is essential for synaptic remodelling and plasticity in the neuronal cells. Misregulation in these processes caused by TDP-43 proteinopathy lead to neurodegenerative diseases such frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Using biochemical analysis and imaging techniques including super-resolution microscopy, we provide evidences for the first time of the postsynaptic localization of TDP-43 in the mammalian synapses; and we show TDP-43 as a component of neuronal mRNP granules. With activity stimulation and different molecular approaches, we further demonstrate activity-dependent mRNP granule dynamics involving disassembly of mRNP granules, release of mRNAs, and activation of local protein translation as long as impairments in models of TDP-43 proteinopathy. This study elucidates the interplay between TDP-43 and neuronal mRNP granules in normal physiology and TDP-43 proteinopathy in regulation of local protein translation and mRNA metabolism in the postsynaptic compartment.
Introduction
Neurodegenerative diseases are a heterogeneous group of disorders characterized by the progressive functional decline of the central nervous system with progressive loss of the structure and the function of neurons in the brain and/or the spinal cord [1] [2] . In neurodegenerative diseases including Alzheimer's disease (AD), frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis ALS and Huntington's disease (HD), one of the common pathological features is the appearance of abnormal protein aggregates [3] [4] [5] [6] [7] [8] [9] . Previous studies have suggested that the pathogenic process of the abnormal protein aggregates involves abnormal protein folding and can result in loss-of-function of multiple nuclear and/or cytosolic proteins [10] . On the other hand, besides the functional loss caused by abnormal protein aggregation, previously published studies have proven that the formation of insoluble protein inclusions also exerts gain-of-toxicity effects that lead to impaired cellular function and neuronal death in the central nervous system [11] [12] [13] . Taken together, the processes of abnormal protein folding and aggregation formation contribute both to loss of normal physiological protein function and gain of cellular toxicity, which ultimately lead to disease phenotypes.
RNA-binding proteins(RPBs) are involved extensively in various forms of neurodegenerative diseases [14] [15] . RPBs are key components of messenger ribonucleoprotein particles(mRNPs), in which RPBs associate and interact with mRNAs to form protein-mRNA complexes that participated in the regulation of sophiscated post-transcriptional gene regulation including pre-mRNA splicing, RNA editing, mRNA transport and local translation [16] . Recent studies have shown that mRNPs can be further assembled into mRNP granules, which are higher-ordered protein-RNA complexes with the cargo mRNAs associated with non-translating ribosomes. These translationally silenced mRNP granules include neuronal RNA transport granules, P bodies and stress granules [17] [18] . Evidences have suggested that the cargo mRNAs in these mRNP granules are translationally paused before completion of the translational initiation and they can transport along axons and dendrites to presynaptic and postsynaptic terminals [19] . Upon appropriate activation signals including synaptic activity, the translationally paused mRNP granules can be further reactivated resulting in local translation in axons, dendrites and synapses [20] [21] [22] . Among different RBPs, TAR DNA-binding protein 43(TDP-43) is a ubiquitously expressed multifunctional DNA/RNA binding protein that is primarily nuclear but shuttles between the cytoplasm and nucleus [23] . was identified as the major component of pathological cytoplasmic inclusions, which are the pathological hallmark of FTLD and ALS [24] [25] . Previous studies have shown that both dominant mutations and overexpression of TDP-43 are sufficient to cause FTLD and/or ALS phenotypes, highlighting the role of TDP-43 in disease pathogenesis [26] [27] [28] . TDP-43 has thousands of mRNA targets, many of which play important role in CNS development and synaptic homeostasis [23] , [29] . Despite its primary nuclear localization, cytosolic TDP-43 isolated from both human and rodent brain cytosolic fractions have been shown to bind to the 3' UTR of numerous target mRNAs [28] . Further studies have also suggested the important role of TDP-43 in mRNA transport and stability. For example, TDP-43 is recognized to be involved in microtubule-dependent bidirectional axonal transport of mRNAs [30] .
Somatodendritic TDP-43 was also shown to be regulate in somatodendritic RNA metabolism [31] . Together, these have suggested a potential role of TDP-43 in neuronal plasticity by regulation of axodendritic local translation and impairment of cytosolic TDP-43 function might be of importance of the pathogenesis of diseases featuring TDP-43 proteinopathy such as FTLD and ALS, yet direct evidence is lacking.
Here, we elucidated the interplay between TDP-43 and neuronal mRNP granule in TDP-43 proteinopathy.Here, we provided evidence of the synaptic localization of cytosolic TDP-43 and for the first time directly visualized the postsynaptic localization of TDP-43 in the mammalian synapses by far field super-resolution microscopy. Next, we showed TDP-43 as a component of neuronal mRNP granule and the neuronal activity-dependent granule dynamics in normal physiological condition as well as in TDP-43 proteinopathy. Our work also provided insight into the involvement of neuronal mNRP granule in pathological TDP-43 inclusions in cellular, animal models and FTLD-TDP patients.
Materials and methods

Animal models
All the experiments were under review and permitted by the Institute of Animal Use and Care Committee at National Cheng Kung University (NCKU), Taiwan. Mice were all bred at NCKU laboratory animal center. The water and food were provided aggregation accompanied with nuclear TDP-43 depletion appears in the brain of FTLD-TDP transgenic mice, which mimic the hallmark of TDP-43 proteinopathy in brains of human FTLD-TDP patients [26] . For protein extraction, mice were sacrificed by rapid cervical dislocation and the region of cortex was isolated. For immunofluorescent staining, mice were anesthetized by IP injection of chloral hydrate with the dose of 400mg/kg prior to transcardial perfusion.
Sub-cellucar fractionation
Subfractionation of mouse brain tissue was performed as described previously with some modifications [32] . Briefly, grossly dissected forebrain tissue is homogenized in buffer (0.32 M sucrose, 20 mM HEPES, pH 7.4, with protease inhibitors) and centrifuged at 1000 × g for 10 min to pellet the membrane fragments and nuclei fraction. The supernatant is collected as the cytosolic fraction, which is then further centrifuged at 17,000 × g for 15 min to obtain the pellet containing crude synaptosome fraction, which are synaptosomes contaminated with mitochondria and microsomes. This crude synaptosome fraction is then further purified using a discontinuous sucrose density gradient consisting of a 1.2 M sucrose layer on the bottom and a 0.8 M sucrose layer on the top. The crude synaptosome suspension is layered on top of the 0.8 M sucrose layer and centrifuged at 54,000 × g for 90 min.
The purified synaptosomal fraction is obtained from the interface of 0.8 M sucrose and 1.2 M sucrose.
Protein extraction
Forebrains containing cortex were resuspended in ice-cold RIPA lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS) containing protease inhibitor cocktail tablet (Roche) and the mixture of phosphatase inhibitor cocktail 2/3 (Sigma Aldrich). Homogenates were centrifuged and supernatants were collected as brain and cell lysates.
Western blot analysis
Proteins (15-30μg) after quantification by the Bradford protein assay (Bio-rad) were resuspended in loading buffer and subjected to polyacrylamide gel for electrophoresis and transferred to nitrocellulose membrane (Whatman). After blocking, membranes were incubated overnight at 4℃ with primary antibodies. Then, membranes were incubated secondary antibodies and developed using Western Lightning ® Plus-ECL (PerkinElmer).
Primary neuronal culture and drug treatment.
Before culture, 20-mm glass coverslips were coated with 1 mg/mL of poly-D-lysine at room temperature for 20 minutes; the coated coverslips were then placed into the bottom of 12-well culture plates. Next, mouse pups at postnatal day 0 were sacrificed and their cerebral cortices were excised under a dissection microscope. Cortical tissues were triturated for disaggregation and plated on poly-D-lysine-coated glass coverslips in Neurobasal medium containing B27 serum-free supplement and antibiotics (50 U/mL penicillin and 50 μg/mL streptomycin). Cultures were incubated at 37°C in an atmosphere of 95% air, 5% CO 2 , and 90% relative humidity. Half of the growth medium was replaced every 2 days. The primary cultured neurons were maintained for 15 to 19 days prior to immunostaining. For repetitive stimulation by KCl [33] , the neurons (15 days in vitro) were exposed to repetitive stimuli by KCl.
Each stimulus consisted of a treatment with 90 mmol/L KCl for 3 min and a spaced recovery for 10 min. The neuronal cells harvested or fixed for further experiments 30 min after the last stimulation.
Immunofluorescence staining
For immunohistochemistry of the mouse brains, mice were anesthetized by chloral hydrate and transcardial perfusion was performed with 4% paraformaldehyde (PFA) in PBS. The brain was isolated and then embedded in paraffin blocks. Paraffin section was performed and brains were sectioned at 10-μm-thick for immunofluorescent staining. The sections were deparaffinized in xylene and covered with citrate buffer to perform antigen retrieval. Then permeabilized with 0.5% Triton X-100(Sigma-Aldrich), blocked with 5% bovine serum albumin for 1 hour at room temperature. After blocking, sections were incubated overnight at 4℃ with primary antibodies, and then incubated with secondary antibodies for 1 hour. The nuclei were counterstained with DAPI (Sigma-Aldrich). The coverslips were mounted with fluorescent mounting medium.
For immunocytochemistry, cells were washed with PBS and fixed with 4% PFA for 15 min. The cells were then permeabilized with 0.1% Triton X-100 and blocked with 5% bovine serum albumin for 1 hour at room temperature. After blocking, sections were incubated overnight at 4℃ with primary antibodies, and then incubated with secondary antibodies for 1 hour. The nuclei were counterstained with DAPI. Images were taken using upright fluorescence microscope (BX51; Olympus) and laser Scanning Confocal Microscope (C1-Si; Nikon).
dSTORM Microscopy Imaging buffer preparation
We used the imaging buffer composition suggested in a previously reported protocol [34] . Single-molecular localization signals were separated using appropriate filters (Andor Technology) and detected using electron-multiplying charge-coupled device camera (iXon Ultra 897; Andor Technology). Before dynamic image movie acquisition, conventional fluorescence images were acquired to determine the region of interest.
Specifically, 10,000 frame image series were recorded with an exposure time of 50 ms (20 frames per second). The acquired image series were then analyzed using MetaMorph® Super-Resolution System (Molecular Devices) to generate reconstructed dSTORM images.
Co-Immunoprecipitation and RNA-Immunoprecipitation
Cells/forebrain tissue were lysed in RIPA lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS) containing protease inhibitor cocktail tablet (Roche) and quantified by the Bradford protein assay (Bio-rad). Proteins (500 μg/1mg) were diluted to 0.5 mg/ml with lysis buffer.
Co-immunoprecipitation assay was performed using the Catch and Release v2. 
Ribopuromycilation assay
Ribopuromycilation assay was performed as described previously with some modifications [35] [36] . Briefly, primary neuronal cells on coverslips were incubated with Neurobasal medium containing B27 serum-free supplement with 1 mg/ml puromycin and 100 μg/ml cycloheximide for 5 min at 37°C. Afterwards, cells were washed with Neurobasal medium containing B27 serum-free supplement and fixed afterwards for 15 min with 4% PFA in PBS. For immunofluorescence detection, cells were then permeabilized with 0.1% Triton X-100 and blocked with 5% bovine serum albumin for 1 hour at room temperature. After blocking, sections were incubated overnight at 4℃ with anti-puromycin antibodies(Millipore), and then incubated with secondary antibodies for 1 hour.
Urea-soluble fraction preparation
For analysis of urea-soluble proteins, forebrain tissues were dissected and extracted with a serial buffers with increasing reducing power as previously described [37] . Briefly, forebrains were extracted sequentially at 5 mL/g The urea-soluble proteins were then subjected to Western blotting.
HEK 293T cell culture and TDP-43 overexpression
Human embryonic kidney (HEK293) cells were maintained in Dulbecco's modified eagle medium (Gibco) containing 10% fetal bovine serum (HyClone), 1mM sodium pyruvate and 1% penicillin/streptomycin solution (Gibco). HEK293 cells were transfected with GFP-TDP-43 by PolyJet™ DNA in vitro transfection reagent (Signagen Laboratories). Cells were seeded into a 6-well plate at a density of 5 x 10 5 cells/well and incubated overnight. Briefly, 2μg of DNA was diluted to 100 μl with serum-free DMEM with high-glucose (4500 mg/L) (Invitrogen). In another tube, 6 μl of PolyJet reagent was diluted with 94 μl of serum-free DMEM with high-glucose.
Diluted PolyJet reagent was added immediately into the diluted DNA solution and gently mixed by pipetting. The mixture was incubated for 15 minutes at room temperature to facilitate the formation of transfection complex. After incubation, DNA/PolyJet complex was added to 6-well plate containing HEK293 cells. After 24 hours, 10 μM of MG-132 (Sigma-Aldrich) was treated for 0, 4, 8 and 12 hours.
Statistical analysis
All data are reported as the mean ± SEM. The statistical significance of differences between means was evaluated by Student's t test. Differences were considered statistically signicant at p < 0.05, as indicated by the asterisks.
Results
TDP-43 in the Mouse CNS
First, we analyzed TDP-43 distribution in the mouse CNS using
Immunofluorescence. We detected TDP-43 in brain areas including the cortical layers and the hippocampus ( Figure S1, a 
Subcellular Localization of TDP-43
Next, we studied the subcellular localization of TDP-43. Subcellular fractions from forebrain of adult mice were performed. Lamin A and PSD-95 were used as internal control of nuclear and purified synaptosome fraction, respectively. The tissue fractionation showed that TDP-43 was detected in all subfractions including nuclear, cytosolic and purified synaptosome fractions. The result suggested that besides its primary nuclear localization, TDP-43 also showed cytosolic localization and potentially enriched synaptic localization (Figure 1, a) .
To further confirm the presence of axodendritic and synaptic TDP-43 molecules, we utilized confocal fluorescence microscope to identify the subcellular localization of TDP-43 in 19 DIV primary mouse cortical neurons. We observed a predominant nuclear localization of TDP-43 with cytosolic TDP-43 puncta also present ( Figure   S2 ) . High magnification images showed that cytosolic TDP-43 puncta distributed along neurites and colocalized with mushroom-like structure of dendritic spines labeled by CamKII (Figure 1, b) . Co-staining with synaptic marker PSD-95 also showed colocalization of TDP-43 and PSD-95 puncta in neurites (Figure 1, c) .
Together, these results suggested that cytosolic TDP-43 molecules have a synaptic subcellular localization in neurons.
Super-Resolution Microscopy Reveals Postsynaptic Localization of TDP-43 in
Dendritic Spines
Hindered Figure S2 ) As previously described, the following mean distance values arise from imaging a three dimensional structure in two dimensions, as a result, only 40% of all synapses with the highest distance were taken into account to select for synapses whose synaptic cleft is tilted out of and perpendicular to the imaging plan [40] . More 
TDP-43 as a Component of Neuronal RNA Granules in vitro and in vivo
Cytosolic TDP-43 binds to numerous target mRNAs in the 3' UTR region [23] .
Previous studies have shown involvement of cytosolic TDP-43 in mRNA transport and stability [30] [41] . Some studies have also proposed that TDP-43 might be involved in neuronal mRNP granules [42] [43] . We wonder whether cytosolic TDP-43
interacts with neuronal mRNP granule component as well as markers and whether cytosolic TDP-43 is involved in the regulation of neuronal mRNP granule function and RNA metabolism. To address this, TDP-43 was analyzed versus STAU2 and FMRP. STAU2 and FMRP were both RNA binding proteins and were identified key components and markers of neuronal mRNP granules [44] . Here, 19 DIV primary cortical neurons were cultured and TDP-43, STAU2 and FMRP were immunolabeled.
Both STAU2 and FMRP showed puncta distribution in the cytosolic and along the neurites with colocalization of TDP-43 and STAU2 as well as TDP-43 and FMRP observed (Figure 4, a) . Next, to further confirm true colocalization of TDP-43 and neuronal granule markers, we utilized super-resolution microscopy. Reconstruction dSTORM images revealed true colocalization of TDP-43 and STAU2 puncta as well as TDP-43 and FMRP puncta (Figure 4, b) .
To investigate i n vito TDP-43, adult mice frozen sections were prepared as Besides fluorescent images, biochemical analysis was also performed. We analyzed co-immunoprecipation from whole brain lysates of adult mice. Briefly, whole brain lysates were mixed with resins, anti-TDP-43 antibody and antibody affinity ligand.
After incubation for 1 hour at room temperature, the elution was analyzed by western blot. The result showed that there was an interaction between TDP-43, STAU2 and FMRP in adult mice brain (Figure 4, d) . Together, these results suggested that 
Impairment of mRNP Granule Mediated Local Translation in TDP-43
Proteinopathy
Next, in order to determine whether the activity-dependent mRNP granule disassembly and subsequent mRNA release were linked to changes in local translation in the dendrites, we conducted ribopuromycilation assay to measure active translation in stimulated and unstimulated WT/Tg neurons. The experimental procedures of ribopuromycilation assay were described in Materials and methods section.
In the neurons, puromycilated puncta were observed distributing along the neurites. (Figure 6, a) In WT neurons, quantification showed that stimulation by KCl significantly increased the number of puromycin labeled puncta, suggesting an increased local translation in the dendrites induced by neuronal activity (Figure 6, b) .
Compared to WT neurons, TDP-43 Tg neurons showed a lower basal translation.
Additionally, in TDP-43 Tg neurons, the activity dependent increase of local translation was not observed and there was no difference in dendritic local translation between KCl stimulated and unstimulated neurons baring TDP-43 proteinopathy (Figure 6, b ) . Furthermore, we analyzed protein level of the above discussed TDP-43 target proteins Map1b, GluR1 and CamKII in unstimulated and KCl stimulated WT/Tg neurons. Western blots were performed with GAPDH as internal control (Figure 6, c) .
Quantification of the protein levels was performed using ImageJ software. The result showed that in WT neurons, the KCl stimulated neurons had 2.04 fold, 3.92 fold and 1.50 fold increased relative protein levels of Map1b, GluR1 and CamKII compared to the unstimulated neurons, respectively. In contrast, there was no difference in TDP-43 target protein levels between Tg neurons with and without stimulation (Figure 6, d) .
Together the RPM results and the western blot results suggested that the above described granule disassembly and subsequent mRNA release were linked to increased local translation in dendrites and increased levels of TDP-43 target proteins.
Importantly, the result further confirmed our hypothesis that the neuronal granule mediated RNA metabolism and local dendritic translation were impaired in model of TDP-43 proteinopathy. In summary, we reported activity-dependent mRNP granule disassembly accompanied by subsequent mRNA release, increase in local translation, increased levels of TDP-43 target proteins and their impairments in TDP-43 proteinopathy.
Additionally, comparing the unstimulated WT and Tg neurons, we also reported a 
Dysregulated RNA Granules as a Component of Pathological TDP-43 Inclusions in FTLD Mouse Model
We elucidated the metabolism of TDP-43 containing mRNP granule, however, the role of neuronal mRNP granule in pathological TDP-43 inclusions remained unclear.
To further elucidate the role of neuronal mRNP granule in pathological TDP-43
inclusions, we investigated whether mRNP granule markers were present in TDP-43 pathological inclusions. First, co-immunoprecipation with anti-TDP-43 antibody showed interaction between TDP-43 and neuronal mRNP granule markers FMRP and STAU2 (Figure 4, d) . Additionally, co-immunoprecipation from 19 DIV WT/Tg neurons performed with anti-FMRP antibody showed increased relative amount of TDP-43 interacting with FMRP in TDP-43 Tg neurons compared to WT neurons (Figure 7, a) . Next, to direct visualize the TDP-43 increase, dSTORM images of immunolabled TDP-43 and FMRP were investigated, in which TDP-43 containing neuronal mRNP granules were identified as colocalizing puncta of TDP-43 and FMRP (Figure 7, b, left panel) . The quantification revealed increased TDP-43 area and increased TDP-43 total intensity per FMRP/TDP-43 colocalized puncta in Tg neurons compared to WT neurons (Figure 7, b, right Figure 7, d) .
Involvement of Neuronal mRNP Granule in the Formation of TDP-43 Cytosolic
Inclusions
Since our evidences had suggested that neuronal mRNP granules were involved in increased in a time-dependent manner (Figure 8, b, left panel) .
In addition, TDP-43 inclusion bodies presenting as dense cytosolic puncta were observed in HEK 293-T cells after 8 and 12 hours of MG-132 treatment (Figure 8, a, middle and right panels) . We further analyzed the average TDP-43 area and total TDP-43 intensity per transfected cell. The analysis showed both increases in TDP-43 area and total TDP-43 intensity per transfected cell in a time-dependent manner in the cells, which revealed the accumulation of cytosolic TDP-43 over time during the process of inclusion body formation (Figure 8, b, middle and right panels) .
Importantly, we also reported that colocalization between mRNP granule marker FRMP and TDP-43 were observed in all time points when cytosolic TDP-43 were present in 4 ,8 and 12 hours after treatment (Figure 8, a) , further suggesting the involvement of mRNP granule component during the accumulation of cytosolic TDP-43 over time.
Taken together, these results suggested not only mRNP granules were present in TDP-43 pathological inclusions, but they were also involved during the process of TDP-43 inclusion formation. Figure S5 
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